Table A1.
GNAH clinical data.
| Clinical Data | Total (n = 287) | Malignancy (n = 185) | Benign (n = 102) |
|---|---|---|---|
| Age, yr (min-max) | 67.5 (21–87) | 68.3 (32–87) | 66.1 (21–87) |
| Sex, male (%) | 181 (63.1) | 110 (59.5) | 71 (69.6) |
| Pathological diagnosis, n (%) | |||
| NSCLC | 145 (50.5) | 145 (78.4) | 0 |
| Adenocarcinoma | 107 (37.3) | 107 (57.8) | |
| Squamous cell carcinoma | 33 (11.5) | 33 (17.8) | |
| Adenosquamous carcinoma | 2 (0.7) | 2 (1.1) | |
| NSCLC | 3 (1.0) | 3 (1.6) | |
| SCLC | 9 (3.1) | 9 (4.9) | 0 |
| Other type of lung malignancy | 7 (2.4) | 7 (3.8) | 0 |
| Malignancy other than in the lung | 24 (8.4) | 24 (13.0) | 0 |
| Negative for malignancy | 58 (20.2) | 0 | 58 (56.9) |
| NA | 44 (15.3) | 0 | 44 (43.1) |
| Methods for pathological diagnosis | |||
| PCNA | 105 (36.6) | 57 (30.8) | 48 (47.1) |
| Surgical operation | 77 (26.8) | 71 (38.4) | 6 (5.9) |
| Bronchoscopy | 4 (1.4) | 4 (2.2) | 0 |
| EBUS-TBNA | 2 (0.7) | 2 (1.1) | 0 |
| Contrast-enhanced Chest CT (≥2 years) | |||
| No growth | 35 (12.2) | 0 | 35 (34.3) |
| Disappearance | 9 (3.1) | 0 | 9 (8.8) |
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; NA, not applicable; PCNA, percutaneous needle aspiration; EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration.